ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Pharmacyclics


Include trials that are no longer recruiting patients.

7 studies were found.
1.RecruitingMotexafin Gadolinium with Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer; Oropharynx Cancer; Larynx Cancer; Hypopharynx Cancer
2.No longer recruitingRadiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Conditions: unspecified adult solid tumor, protocol specific; brain metastases; Quality of Life
3.RecruitingStudy of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Conditions: Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Lung Neoplasms
4.RecruitingA Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Conditions: Glioma; Glioblastoma; Astrocytoma; Oligodendroglioma; Brain Neoplasm
5.No longer recruitingA Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia; Leukemia, Lymphocytic, Chronic
6.RecruitingStudy of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Conditions: Lymphoma; Non-Hodgkin's Lymphoma
7.RecruitingStudy of Neurologic Progression with Motexafin Gadolinium and Radiation Therapy (SMART)
Conditions: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act